SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Haemonetics held its 2026 annual shareholder meeting on July 24, 2026, with voting results on five proposals: election of eight directors, advisory vote on named executive officer compensation, ratification of Ernst & Young LLP as auditor, and approval of amendments to the 2019 Long-Term Incentive Compensation Plan and 2007 Employee Stock Purchase Plan.
View raw filing on EDGAR →The 6-K discloses results of an Extraordinary General Meeting of Shareholders held on July 28, 2026, with voting outcomes on two proposals: (1) approval of a new three-year compensation policy for directors and officers, and (2) approval of an employment agreement with the new President and CEO, Dr. Chen Lichtenstein. Both proposals were approved. This is a direct disclosure of shareholder vote results, material to investors as it confirms executive leadership and compensation governance changes.
View raw filing on EDGAR →Tempest Therapeutics held a special stockholder meeting on July 27, 2026 to vote on a Certificate of Amendment proposal to modify voting requirements and permit written consent. The proposal failed to achieve the required 75% supermajority vote, and the meeting was adjourned to August 17, 2026 to allow additional voting time.
View raw filing on EDGAR →This exhibit discloses the results of Karooooo Limited's Annual General Meeting held on July 28, 2026, including detailed voting outcomes on six resolutions covering routine business (director re-appointment, financial statement adoption, non-executive director remuneration, auditor re-appointment) and special business (share purchase authorization, share issuance authorization). The tabular presentation of votes cast for, against, and abstained on each resolution is the hallmark of shareholder_vote_results disclosure.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from a Special Meeting held on July 28, 2026. The filing reports the voting outcomes on the Merger Proposal to adopt the Agreement and Plan of Merger with USA Rare Earth, Inc., showing 50,053,327 votes FOR, 550,821 AGAINST, and 199,667 ABSTAIN, with stockholders approving the merger. This is material as it represents a fundamental change of control transaction approved by shareholders.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Park Aerospace's Annual Meeting of Shareholders held on July 21, 2026. The filing presents voting results for director elections (six directors), an advisory vote on named executive officer compensation, and ratification of the independent auditor (CohnReznick LLP). All three matters are routine shareholder votes with clear vote tallies, making this unambiguously a shareholder_vote_results event.
View raw filing on EDGAR →Birchtech Corp. held its 2026 Annual Meeting of Stockholders on July 23, 2026, with final voting results disclosed for four proposals: election of four board directors, ratification of independent auditors (Rosenberg Rich Baker Berman, P.A.), advisory approval of named executive officer compensation, and amendment to decrease authorized common shares from 150 million to 50 million.
View raw filing on EDGAR →The filing discloses results of the Company's 2026 annual meeting of stockholders held on July 22, 2026, including election of nine directors, ratification of Grant Thornton as independent auditor, advisory vote on executive compensation, and approval of stock plan amendments. Item 5.07 explicitly covers shareholder vote results, and the detailed voting tallies and outcomes are material governance matters affecting investor understanding of board composition and corporate governance.
View raw filing on EDGAR →This exhibit is a proxy card for an Extraordinary General Meeting scheduled for 17 August 2026, soliciting shareholder votes on five resolutions including a 1:20 reverse share split, share redesignation into Class A and Class B shares, and adoption of amended memorandum and articles of association. While this is technically a proxy solicitation document rather than a vote *result*, it discloses the material proposals being voted on—particularly the reverse split and share class restructuring—which are governance and capital structure events material to investors. The reverse split and redesignation represent a significant corporate action requiring shareholder approval.
View raw filing on EDGAR →This Item 5.07 discloses the results of a special shareholder meeting held on July 24, 2026, where shareholders voted on three proposals: approval of a private placement issuance exceeding 20% of outstanding common stock at below-minimum pricing, approval of a shelf offering issuance also exceeding 20% at below-minimum pricing, and approval of discretionary authority to the Chairman. The filing presents final voting tallies for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results. The dilutive equity issuances being approved are material to investors.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of an Annual Meeting of Stockholders held on July 23, 2026, including the election of seven directors and ratification of BPM LLP as independent auditor. The filing presents voting tallies for each director nominee and the auditor ratification vote, which is the core purpose of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →QT Imaging held its 2026 Annual Meeting of Stockholders on July 28, 2026, with stockholders voting to approve three matters: election of Class II directors Zeev Weiner and Bryan Timm, ratification of BPM LLP as independent auditor, and approval of an amendment to the 2024 Equity Incentive Plan to increase authorized shares.
View raw filing on EDGAR →This exhibit announces the results of an extraordinary general meeting held on July 28, 2026, where shareholders voted on five resolutions: (1) change of company name, (2) increase of authorized share capital from US$250,000 to US$31,250,000, (3) share consolidation at a 1-for-5 to 1-for-10 ratio, (4) redesignation of 182,983 Class A shares to Class B shares, and (5) omnibus resolutions. The filing explicitly provides voting tabulations for each resolution, including votes in favor, against, and abstained/withheld. These capital structure changes—particularly the 125-fold increase in authorized capital and the discretionary share consolidation—are material to investors' assessment of ownership dilution and voting power.
View raw filing on EDGAR →The filing discloses results of a special shareholder meeting held on July 21, 2026, under Item 5.07. The three proposals voted on include: (1) approval of a merger agreement with steute Industrial Controls, Inc., which passed with 2,339,552 votes for; (2) advisory approval of executive compensation, which passed; and (3) adjournment authority, which passed. The merger proposal is material to investors as it represents a change of control transaction where the Company will become a wholly owned subsidiary of Parent.
View raw filing on EDGAR →At the July 23, 2026 Annual Meeting of Stockholders, all four proposals were approved: election of seven directors, ratification of BDO USA as independent auditor, advisory vote on named executive officer compensation, and frequency of future advisory votes on compensation.
View raw filing on EDGAR →The 6-K discloses the results of a Special General Meeting of Shareholders held on July 27, 2026, where shareholders voted upon and approved the sole agenda item after an initial adjournment due to lack of quorum. This is a direct disclosure of shareholder vote results, matching the definition of Item 5.07 (shareholder_vote_results). The materiality is high because shareholder votes on special matters are typically material to investors' assessment of corporate governance and strategic decisions.
View raw filing on EDGAR →The press release announces results of an Extraordinary General Meeting held on July 24, 2026, where shareholders approved all resolutions presented, specifically authorizing the Board to implement a share consolidation and amend the Company's Memorandum and Articles of Association. This is a direct disclosure of shareholder vote results, matching the definition of Item 5.07 disclosure type.
View raw filing on EDGAR →Stockholders approved four proposals at the July 21, 2026 Annual Meeting: amendment to extend the business combination deadline to June 22, 2027; amendment to the trust agreement extending the completion timeline; election of five board nominees; and ratification of WithumSmith+Brown, PC as independent auditor. Additionally, 5,869,285 shares were tendered for redemption, materially affecting the company's capital structure and ongoing obligations.
View raw filing on EDGAR →The filing's primary disclosure is Item 5.07, which reports the results of an extraordinary shareholder meeting held on July 21, 2026. Shareholders voted to approve amendments to the Investment Management Trust Agreement and the company's memorandum and articles of association, both enabling KVAC to extend its business combination period by up to four additional three-month periods. The voting results show overwhelming approval (4,982,736 FOR vs. 295,218 AGAINST on both proposals), which is material to investors as it directly affects the timeline for the SPAC's business combination obligation.
View raw filing on EDGAR →This Item 5.07 disclosure reports on the Annual Meeting of Stockholders held on July 24, 2026. Although the meeting was recessed due to failure to achieve quorum, the filing documents the submission of matters to a vote of security holders—specifically the election of directors, ratification of the independent auditor, and a proposed sale of 2,000,000 shares. The recess and need for additional proxy solicitation are material developments affecting shareholder governance and the timing of key corporate actions.
View raw filing on EDGAR →This 6-K furnishes the results of Vodafone's Annual General Meeting held on 27 July 2026, disclosing the outcome of 26 shareholder resolutions (with Resolution 7 withdrawn). The document presents detailed poll results for each resolution, including votes for/against and percentages, covering director elections, dividend approval, auditor re-appointment, and capital authorization matters. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, material because it documents shareholder approval of key governance and financial decisions including board composition, remuneration policy, and dividend declaration.
View raw filing on EDGAR →Shareholders approved a business combination merger agreement, name change to MicroTouch Inc., Nasdaq compliance measures, charter amendments, and election of five directors at an extraordinary general meeting held on July 23, 2026. The voting results for all six proposals are detailed with explicit vote counts.
View raw filing on EDGAR →Constellation Brands held its Annual Meeting of Stockholders on July 22, 2026, with shareholders voting on four matters: election of 12 directors, ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and approval of an amended Long-Term Stock Incentive Plan. Final vote tallies were disclosed for each proposal.
View raw filing on EDGAR →The 6-K furnishes a press release announcing "the Results of Its 2026 Annual General Meeting of Shareholders" dated July 24, 2026. This disclosure of shareholder meeting outcomes directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders. Annual meeting results are material to investors as they typically include board elections, compensation approvals, and other governance matters.
View raw filing on EDGAR →The 6-K body explicitly states that Exhibit 1 is "a copy of the press release issued by EuroDry Ltd. on July 24, 2026: EuroDry Ltd. Announces the Results of Its 2026 Annual General Meeting of Shareholders." This is a disclosure of shareholder vote results from an annual general meeting, which is a material governance event that would affect investor assessment of board composition, compensation approvals, and other shareholder-approved matters.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from McKesson's July 22, 2026 Annual Meeting of Shareholders, covering three items: election of 11 directors, ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents final vote tallies (votes for, against, abstentions, and broker non-votes) for each matter, which is the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of AmeriServ Financial's 2026 annual shareholder meeting held on July 23, 2026, including voting outcomes on three proposals: election of three Class I directors (Richard W. Bloomingdale, David J. Hickton, and Daniel A. Onorato), an advisory vote on named executive officer compensation, and ratification of S.R. Snodgrass P.C. as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core disclosure, making this a clear shareholder_vote_results event that is material to investors assessing governance and board composition.
View raw filing on EDGAR →This Item 5.07 discloses the results of Hilltop Holdings' 2026 Annual Meeting of Stockholders held on July 23, 2026, where stockholders voted on three proposals: election of 13 directors, advisory approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing presents voting results on alternative bases due to pending Ford Litigation disputing voting authority over 15.5 million shares (Diamond A Financial), demonstrating material shareholder governance activity with significant voting implications.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of a special stockholder meeting held on July 24, 2026, where shareholders voted on three proposals: approval of warrant exercise share issuance under Nasdaq Rule 5635(d), approval of a reverse stock split (1-for-5 to 1-for-70 ratio) to maintain Nasdaq listing compliance, and authorization of meeting adjournments. All three proposals passed with clear majorities. The reverse split approval is particularly material as it directly addresses Nasdaq continued listing requirements and signals potential delisting risk mitigation.
View raw filing on EDGAR →Surf Air Mobility held its Annual Meeting of Stockholders on July 24, 2026, with voting results including the election of two Class C directors (Tyler Painter and Sudhin Shahani), ratification of PwC as independent auditor, and approval of a reverse stock split authorization (2:1 to 6:1 ratio).
View raw filing on EDGAR →The 6-K discloses results of an extraordinary general meeting held on July 15, 2026, where shareholders voted on two resolutions: (1) a capital reorganisation involving a reduction of par value from US$1.25 to US$0.00001 per share and subdivision of authorised shares, and (2) an amendment to the 2025 Omnibus Equity Plan to increase available shares by 15 million and add an evergreen provision. Both proposals were approved with vote tallies provided. This is a classic shareholder vote results disclosure material to investors assessing capital structure and equity dilution.
View raw filing on EDGAR →GCL Global Holdings Ltd is soliciting shareholder votes at an extraordinary general meeting scheduled for August 7, 2026, on four substantive proposals: authorization for a 10:1 to 30:1 share consolidation with board discretion on timing and ratio, increase in authorized share capital post-consolidation, adoption of amended memorandum and articles of association, and meeting adjournment authority. The share consolidation and capital restructuring represent material governance and capital structure events affecting investor assessment.
View raw filing on EDGAR →This 8-K Item 5.07 discloses the results of Tenon Medical's 2026 Annual Meeting of Stockholders held on July 23, 2026. The filing reports voting outcomes on six matters: election of seven directors, ratification of auditors (Haskell & Whitee LLP), approval of a reverse stock split (1:2 to 1:35 ratio), approval of shares underlying convertible debt from March 2026 financing, approval of future dilutive issuances under Nasdaq rules, and adjournment authority. All six proposals were approved. The reverse stock split and dilutive issuance approvals are material capital structure events affecting shareholders.
View raw filing on EDGAR →The exhibit is a press release announcing the results of Euroholdings' 2026 Annual Meeting of Shareholders held on July 23, 2026. It discloses that shareholders elected two Class B directors (Panagiotis Kyriakopoulos and Christos Triantafillidis) and ratified the appointment of Deloitte as independent auditors. This is a direct disclosure of shareholder vote results, which is material to investors as it affects board composition and auditor selection.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Booz Allen Hamilton's Annual Meeting of Stockholders held on July 22, 2026, covering four proposals: election of ten directors, ratification of Ernst & Young LLP as independent auditor, advisory vote on named executive officer compensation, and a stockholder proposal. The filing presents final vote tallies for each matter, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →On July 22, 2026, the Company held a Special Meeting of Stockholders at which shareholders voted on six proposals: election of six directors, ratification of Sadler, Gibb & Associates as auditors, advisory approval of named executive officer compensation, approval of the 2025 and 2026 equity incentive plans, and adjournment authority. Vote counts for each proposal are disclosed.
View raw filing on EDGAR →The 6-K discloses results of an Annual and Extraordinary General Meeting of Shareholders held on July 23, 2026, where shareholders voted on and approved all agenda items except Proposal No. 6. This is a direct disclosure of shareholder vote results, which is material to investors as it reflects governance decisions and shareholder approval of corporate actions.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Jazz Pharmaceuticals' 2026 Annual General Meeting held on July 23, 2026. The filing reports voting outcomes on six proposals including director elections (Proposal 1), auditor ratification (Proposal 2), executive compensation approval (Proposal 3), and board authority matters (Proposals 4-5), with detailed vote tallies for each. This is a quintessential Item 5.07 shareholder vote results disclosure that is material to investors as it reflects shareholder approval of key governance and compensation matters.
View raw filing on EDGAR →System1 held its 2026 annual meeting of stockholders on July 22, 2026, with voting results on three proposals: approval of Series A Cumulative Convertible Preferred Stock issuance, election of three Class I directors (Michael Blend, Caroline Horn, and Taryn Naidu), and ratification of Deloitte and Touche LLP as independent auditor.
View raw filing on EDGAR →Brown-Forman held its Annual Meeting of Stockholders on July 23, 2026. Shareholders voted on three proposals: election of 11 directors (all elected), advisory approval of executive compensation (approved), and ratification of Ernst & Young LLP as independent auditor (ratified).
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on July 22, 2026. The filing reports the voting outcomes for three proposals: election of seven directors, advisory approval of named executive officer compensation, and ratification of Crowe LLP as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non-votes) for each proposal are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →This 8-K Item 5.07 discloses the results of a special stockholder meeting held on July 23, 2026, where shareholders voted on two proposals: (1) adoption of a Merger Agreement with Sun Pharmaceutical entities, which passed with 192.8 million votes for and 2.6 million against, and (2) advisory approval of merger-related executive compensation, which also passed. The disclosure includes voting tallies, quorum information, and record date details—all hallmarks of shareholder vote results. The merger itself is material, and the shareholder approval is a critical milestone in the transaction's completion.
View raw filing on EDGAR →This Item 5.07 disclosure presents the final voting results from Maison Solutions Inc.'s annual meeting of stockholders held on July 22, 2026. The filing reports detailed vote tallies for two proposals: (1) election of five directors (John Xu, Alexandria M. Lopez, Mark Willis, Bin Wang, and Dr. Xiaoxia Zhang) and (2) ratification of Kreit & Chiu CPA LLP as independent auditors for fiscal year 2027. This is a classic shareholder_vote_results event, as it discloses the outcome of matters voted upon at an annual meeting of security holders.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on July 22, 2026, covering four proposals: director elections, say-on-pay advisory vote, auditor ratification, and a reverse stock split amendment. The filing directly reports vote tallies (For, Against, Withheld/Abstain, Broker Non-Votes) for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures. The reverse stock split proposal is particularly material as it addresses Nasdaq compliance concerns regarding minimum bid price requirements.
View raw filing on EDGAR →The 6-K discloses results of Tokyo Lifestyle Co., Ltd.'s 20th Annual General Meeting of Shareholders held on June 26, 2026. The filing reports shareholder approval of five agenda items: financial statements, Articles of Incorporation amendments, a year-end dividend of JPY1.890 per share, appointment of Sakurazaka Audit Corporation as Accounting Auditor, and appointment of three Corporate Auditors. This is a classic shareholder vote results disclosure under Item 5.07 equivalent, and the dividend approval and auditor/corporate auditor appointments are material governance and capital allocation matters.
View raw filing on EDGAR →The filing discloses results of a special meeting of stockholders held on June 22, 2026, where shareholders voted on four proposals: extension of the business combination deadline, amendment to the trust agreement, elimination of redemption limitations, and adjournment. Item 5.07 provides detailed voting results for each proposal, with overwhelming approval (1,897,828 FOR votes vs. 900 AGAINST on all substantive proposals). This is a classic shareholder vote results disclosure under Item 5.07, and the outcomes are material to a SPAC's continued operations and timeline.
View raw filing on EDGAR →The document is a distance voting ballot for an Extraordinary General Meeting scheduled for 08/28/2026, not a report of voting results. It presents three material merger resolutions (Juno, Tijoá Energia, Retiro Baixo, and NE Janapu) for shareholder approval, but the vote has not yet occurred. This is a pre-meeting disclosure furnishing voting instructions and merger proposals, not a post-meeting results announcement. The most defensible classification is `shareholder_vote_results` as the closest fit, though technically this is a voting ballot preceding the meeting rather than results following it; alternatively, this could be `ma_activity` given the four mergers proposed, but the document's primary function is shareholder voting mechanics rather than M&A announcement.
View raw filing on EDGAR →The 6-K furnishes a distance voting ballot for an Extraordinary General Meeting (EGM) scheduled for 08/28/2026, presenting three material merger resolutions: approval of the mergers of Juno Participações, Tijoá Participações, Retiro Baixo Energética, and SPE Nova Era Janapu Transmissora into AXIA Energia. While this is technically a pre-vote notice rather than post-vote results, it discloses the shareholder voting mechanism and substantive M&A activity requiring shareholder approval. The mergers themselves constitute material acquisition activity under the taxonomy, though the document is the voting ballot rather than results announcement.
View raw filing on EDGAR →This is a call notice for an Extraordinary General Meeting scheduled for August 28, 2026, not a report of voting results. The document announces shareholder approval items (mergers of Juno, Tijoá Energia, Retiro Baixo, and NE Janapu into AXIA Energia) but does not disclose the outcome of a vote. The proper classification should be governance-related, but the taxonomy lacks a specific "shareholder_meeting_notice" or "shareholder_vote_scheduled" type. This is a pre-vote notice, not a post-vote result.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from the July 22, 2026 Annual Meeting. The filing reports voting outcomes on four proposals: election of five directors, approval of a stock plan amendment, advisory approval of executive compensation, and ratification of the auditor (Baker Tilly US, LLP). All proposals passed with majority support, and the detailed vote tallies are provided for each nominee and proposal.
View raw filing on EDGAR →